CH679372A5 - - Google Patents

Download PDF

Info

Publication number
CH679372A5
CH679372A5 CH131289A CH131289A CH679372A5 CH 679372 A5 CH679372 A5 CH 679372A5 CH 131289 A CH131289 A CH 131289A CH 131289 A CH131289 A CH 131289A CH 679372 A5 CH679372 A5 CH 679372A5
Authority
CH
Switzerland
Prior art keywords
stage
benzopyrone
portions
preparation
salt
Prior art date
Application number
CH131289A
Other languages
German (de)
English (en)
Inventor
Christian Dr Med Vet Fricker
Original Assignee
Vet Gerhard Stuker Dr Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vet Gerhard Stuker Dr Med filed Critical Vet Gerhard Stuker Dr Med
Priority to CH131289A priority Critical patent/CH679372A5/de
Priority to EP19900903746 priority patent/EP0419604A1/fr
Priority to PCT/CH1990/000072 priority patent/WO1990011759A1/fr
Publication of CH679372A5 publication Critical patent/CH679372A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH131289A 1989-04-07 1989-04-07 CH679372A5 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH131289A CH679372A5 (fr) 1989-04-07 1989-04-07
EP19900903746 EP0419604A1 (fr) 1989-04-07 1990-03-15 Composition a deux constituants contenant de la coumarine ou du calcium dobesilate pour le traitement de l'osteoarthrose
PCT/CH1990/000072 WO1990011759A1 (fr) 1989-04-07 1990-03-15 Composition a deux constituants contenant de la coumarine ou du calcium dobesilate pour le traitement de l'osteoarthrose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH131289A CH679372A5 (fr) 1989-04-07 1989-04-07

Publications (1)

Publication Number Publication Date
CH679372A5 true CH679372A5 (fr) 1992-02-14

Family

ID=4207501

Family Applications (1)

Application Number Title Priority Date Filing Date
CH131289A CH679372A5 (fr) 1989-04-07 1989-04-07

Country Status (3)

Country Link
EP (1) EP0419604A1 (fr)
CH (1) CH679372A5 (fr)
WO (1) WO1990011759A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645081A (en) * 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
WO2008020033A1 (fr) * 2006-08-16 2008-02-21 Action Medicines, S.L. Utilisation de dérivés de 2,5-dihydrobenzène pour le traitement de l'arthrite et de la douleur
DE502007002101D1 (de) * 2007-03-12 2010-01-07 Dobavet Gmbh Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581885B2 (en) * 1984-03-01 1989-03-09 Lamorna Investments Proprietary Limited Treatment of high protein oedemas by direct application of benzo-pyrones
US5096887A (en) * 1984-03-01 1992-03-17 Lamorna Investments Proprietary Limited Treatment of high protein oedemas

Also Published As

Publication number Publication date
WO1990011759A1 (fr) 1990-10-18
EP0419604A1 (fr) 1991-04-03

Similar Documents

Publication Publication Date Title
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
DE2813480C2 (de) Arzneimittel-Depotpräparat vom Mehrfacheinheitsdosen-Typ
DE3927113C2 (de) Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
DE3907649C2 (de) Arzneimittel, geeignet bei der Bekämpfung von Viren und zur Immunstimulierung
CH660969A5 (de) Verwendung von thiadiazinverbindungen.
DE2921312A1 (de) Pharmazeutisches mittel und dessen verwendung bei einer vollstaendig parenteralen ernaehrung
DE69917796T2 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
DE3424781A1 (de) Verwendung von l-carnosin zur tumorbehandlung
Pohle et al. Studies of the Effect of Roentgen Rays on the Liver Histological Changes in the Liver of Rats Following Exposure to Single Graded Doses of Filtered Roentgen Rays
DE2803869A1 (de) Injizierbare embolisations- und okklusionsloesung
CH679372A5 (fr)
DE60124516T2 (de) Kombination des lezithins mit ascorbinsäure
DE3152319T1 (fr)
Gilani et al. Aluminum poisoning and chick embryogenesis
DE60216292T2 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
DE1900772C3 (de) Salz aus N,N-Dimethylbiguanid und p-Chlorphenoxyessigsäure sowie dieses enthaltende Arzneimittel
Best et al. Studies in experimental shock
EP0670721B1 (fr) Medicament utilise dans le traitement et la prophylaxie des maladies osseuses et articulaires
Kallfelz et al. Correlation between 47Ca absorption and intestinal calcium-binding activity in the golden hamster
Tang et al. A specific antagonist of vasopressin produced plasma hyperosmolality and reduced ischemic-induced cerebral edema in rats
DE1964504A1 (de) Arzneimittelzubereitung mit einem Gehalt an 3-Butylamino-4-phenoxy-5-sulfamyl-benzoesaeure und deren Salzen
DE69721077T2 (de) Verwendung von 2-methoxyphenyl-1-methyl-5p-methyl-benzoylpyrrol-2-acetamido-acetat zur herstellung eines antientzündungsmittels mit vorbeugung von magenhypersekretion und nierenfunktionsstörung
DE2844534C2 (fr)
RU2700416C1 (ru) Способ профилактики соматических осложнений в интра- и послеоперационном периоде у пациентов с эндопротезированием тазобедренного и коленного суставов
Mann The liver and medical progress

Legal Events

Date Code Title Description
PL Patent ceased